Alphamab starts Phase I infertility study

Suzhou Alphamab Co. Ltd. (Suzhou, China) started a Chinese Phase I study of KN015, a long-acting human follicle stimulating hormone (FSH), to treat infertility. Compared with approved FSH treatments, which require multiple injections during a treatment cycle, KN015 could require only one subcutaneous injection, the company said. The candidate is Alphamab's first to enter the clinic. ...